Literature DB >> 31489230

Management of clinical T2N0 esophageal cancer: a review.

Patrick Vining1, Thomas J Birdas1.   

Abstract

While management of locally advanced esophageal cancer has mostly involved multimodality therapy, management of clinical T2N0 patients has been more controversial, primarily as a result of inaccurate clinical staging with existing modalities. This review article examines current literature on this topic and provides recommendations for management of individual patients.

Entities:  

Keywords:  Esophageal cancer; esophagectomy; neoadjuvant therapy

Year:  2019        PMID: 31489230      PMCID: PMC6702392          DOI: 10.21037/jtd.2019.07.85

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  20 in total

1.  Long-term outcomes following neoadjuvant chemoradiotherapy in patients with clinical T2N0 esophageal squamous cell carcinoma.

Authors:  W-H Chen; Y-K Chao; H-K Chang; C-K Tseng; Y-C Wu; Y-H Liu; M-J Hsieh; H-P Liu
Journal:  Dis Esophagus       Date:  2011-09-23       Impact factor: 3.429

2.  Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.

Authors:  Paul J Speicher; Asvin M Ganapathi; Brian R Englum; Matthew G Hartwig; Mark W Onaitis; Thomas A D'Amico; Mark F Berry
Journal:  J Thorac Oncol       Date:  2014-08       Impact factor: 15.609

3.  T2N0M0 esophageal cancer.

Authors:  Thomas W Rice; David P Mason; Sudish C Murthy; Gregory Zuccaro; David J Adelstein; Lisa A Rybicki; Eugene H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2007-01-09       Impact factor: 5.209

4.  Clinical stage T1-T2N0M0 oesophageal cancer: accuracy of clinical staging and predictive factors for lymph node metastasis.

Authors:  Sumin Shin; Hong Kwan Kim; Yong Soo Choi; Kwhanmien Kim; Young Mog Shim
Journal:  Eur J Cardiothorac Surg       Date:  2014-03-14       Impact factor: 4.191

Review 5.  Management of T2 esophageal cancer.

Authors:  Manu Sancheti; Felix Fernandez
Journal:  Surg Clin North Am       Date:  2012-08-11       Impact factor: 2.741

6.  Treatment of clinical T2N0M0 esophageal cancer.

Authors:  Thomas J Hardacker; DuyKhanh Ceppa; Ikenna Okereke; Karen M Rieger; Shadia I Jalal; Julia K LeBlanc; John M DeWitt; Kenneth A Kesler; Thomas J Birdas
Journal:  Ann Surg Oncol       Date:  2014-07-22       Impact factor: 5.344

7.  Significant understaging is seen in clinically staged T2N0 esophageal cancer patients undergoing esophagectomy.

Authors:  J P Dolan; T Kaur; B S Diggs; R A Luna; B C Sheppard; P H Schipper; B H Tieu; G Bakis; G M Vaccaro; J M Holland; K M Gatter; M A Conroy; C A Thomas; J G Hunter
Journal:  Dis Esophagus       Date:  2015-02-24       Impact factor: 3.429

8.  Two thousand transhiatal esophagectomies: changing trends, lessons learned.

Authors:  Mark B Orringer; Becky Marshall; Andrew C Chang; Julia Lee; Allan Pickens; Christine L Lau
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

9.  Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study.

Authors:  Sheraz R Markar; Caroline Gronnier; Arnaud Pasquer; Alain Duhamel; Hélène Beal; Jérémie Théreaux; Johan Gagnière; Gil Lebreton; Cécile Brigand; Bernard Meunier; Denis Collet; Christophe Mariette
Journal:  Eur J Cancer       Date:  2016-01-23       Impact factor: 9.162

10.  Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database.

Authors:  Traves D Crabtree; Andrzej S Kosinski; Varun Puri; William Burfeind; Ankit Bharat; G Alexander Patterson; Wayne Hofstetter; Bryan F Meyers
Journal:  Ann Thorac Surg       Date:  2013-05-31       Impact factor: 4.330

View more
  1 in total

1.  Demographic, endoscopic and histological profile of esophageal cancer at the Gastroenterology Department of Maputo Central Hospital from January 2016 to December 2018.

Authors:  Muhammad Ismail; Liana Mondlane; Michella Loforte; Luzmira Dimande; Sheila Machatine; Carla Carrilho; Jahit Sacarlal
Journal:  Pan Afr Med J       Date:  2022-02-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.